Nephrology
Dialysis
0
Pipeline Programs↗
5
Active Trials↗
9
Companies Involved↗
Dialysis is an early-stage landscape with 0 programs across 9 companies. The most active players are Sanofi, Merck & Co., Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
35
clinical trials
Completed21 · 60%
Unknown status6 · 17%
Recruiting4 · 11%
Terminated2 · 6%
Withdrawn1 · 3%
Active, not recruiting1 · 3%
Clinical Trials
Trial Activity
35 trials
Monitoring of the Bone Free Flaps With Microdialysis
Recruiting·—·N/A·NCT03935139·40 enrolled
DIALYSIS-TIR Study
Active, not recruiting·UUniversity of Texas Southwestern Medical Center·Phase 4·NCT06042153·43 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)